Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 9/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.63 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.63 |
| ▸ | PTGES | O14684 | 1/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.63 |
| ▸ | POLL | Q9UGP5 | 7/20 | 0.47 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
| ▸ | MET | P08581 | 3/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xanthochymol SCHEMBL18176145 | 1.00 | EP300 (0.63) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Xanthochymol SCHEMBL14867275 | 1.00 | EP300 (0.63) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Isogarcimultiflorone F SCHEMBL31345865 | 1.00 | EP300 (0.63) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Guttiferone F SCHEMBL23815733 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Guttiferone F SCHEMBL25049796 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Guttiferone F SCHEMBL23815760 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Garcinol SCHEMBL294532 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Guttiferone F SCHEMBL23815758 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Guttiferone F SCHEMBL23607580 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 | |
| Guttiferone F SCHEMBL19565392 | 0.92 | EP300 (0.75) | EP300HDAC11KAT2BPTGESHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024478-A1 | COMPOSITIONS FOR THE MODULATION OF TASTE | IXORA SCIENTIFIC INC. (US) | 2025-01-30 | — | — | WO | claimed |
| CN-111743883-A | Benzophenone derivative composition, preparation method and application thereof | 中南民族大学 | 2020-10-09 | — | — | CN | claimed |
| CN-109020945-A | A kind of different gamboge amphyl, preparation method and application | 贵州省中国科学院天然产物化学重点实验室 | 2018-12-18 | — | — | CN | claimed |
| CN-104274831-A | Composition based on naturally derived peptide and inflammation inhibitor and/or anti-oxidation compound | SOO TUCK POOI | 2015-01-14 | — | — | CN | claimed |
| US-8329743-B2 | Compositions and its use in treating obesity or inducing weight loss | SAMI LABS LIMITED (IN) | 2012-12-11 | — | — | US | claimed |
| US-20120178801-A1 | COMPOSITIONS AND ITS USE IN TREATING OBESITY OR INDUCING WEIGHT LOSS | SAMI LABS LIMITED (IN) | 2012-07-12 | — | — | US | claimed |
| JP-11139965-A | — | — | None | — | — | JP | disclosed |
| US-12447188-B2 | Compositions and methods for the antiseptic treatment of biofilms on mammalian tissue | AVADIM HOLDINGS, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2025024478-A1 | COMPOSITIONS FOR THE MODULATION OF TASTE | IXORA SCIENTIFIC INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| US-20240269106-A1 | SMALL MOLECULE MODULATOR TARGETING A RARE HISTONE MODIFICATION REGULATING ADIPOGENESIS AND PHARMACEUTICAL FORMULATION THEREOF | COUNCIL OF SCIENT AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN (IN) | 2024-08-15 | — | — | US | disclosed |
| EP-4346786-A1 | SMALL MOLECULE MODULATOR TARGETING A RARE HISTONE MODIFICATION REGULATING ADIPOGENESIS AND PHARMACEUTICAL FORMULATION THEREOF | Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) (IN) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022254465-A1 | SMALL MOLECULE MODULATOR TARGETING A RARE HISTONE MODIFICATION REGULATING ADIPOGENESIS AND PHARMACEUTICAL FORMULATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2022-12-08 | — | — | WO | disclosed |
| EP-2070543-A1 | High-efficiency procedure for preparing standarized hydroalcoholic propolis extract | Bios Line S.p.a. (IT) | 2009-06-17 | — | — | EP | disclosed |
| EP-1602354-B1 | Use of polyglutamic acid or its salts | MEIJI SEIKA KAISHA (JP) | 2008-11-05 | — | — | EP | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
| US-20060165636-A1 | Hair treatment composition and hair cosmetic for damaged hair | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1602354-A1 | HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR | Meiji Seika Kaisha, Ltd. (JP) | 2005-12-07 | — | — | EP | disclosed |
| US-5972357-A | CONTAINING POLYISOPRENYLATED BENZOPHENONE DERIVATIVES AS EFFECTIVE INGREDIENTS AND HAVING A VARIETY OF FUNCTIONS FOR MAINTAINING HEALTH SUCH AS ANTI-ULCER ACTIVITY, THE MAILLARD REACTION INHIBITING ACTIVITY, ANTI-OXIDATION ACTIVITY, OXYGEN | KIKKOMAN CORPORATION (JP) | 1999-10-26 | — | — | US | disclosed |
| JP-H11139965-A | ANTITUMOR AGENT | KIKKOMAN CORP | 1999-05-25 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165636-A1 | Hair treatment composition and hair cosmetic for damaged hair | CUTA, COL14A1, PRKDC | EP300 1222/4885HDAC11 626/4885KAT2B 876/4885 |
| US-20240269106-A1 | SMALL MOLECULE MODULATOR TARGETING A RARE HISTONE MODIFICATION REGULATING ADIPOGENESIS AND PHARMACEUTICAL FORMULATION THEREOF | EP300, HDAC1, HDAC3 | EP300 1/4885HDAC11 5/4885KAT2B 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.